Zhaoke Ophthalmology Announces NMPA Acceptance of New Drug Application for NVK002 (Atropine Sulphate Eye Drops 0.02%) for the Treatment of Myopia Progression in Children

Zhaoke Ophthalmology and Jamjoom Pharma Forge Landmark Partnership to Revolutionize Dry Eye Treatment in the Middle East

Zhaoke Ophthalmology Expands its Footprint in the U.S. Partnering with Leading US Pharma, Somerset Therapeutics LLC

Zhaoke Ophthalmology’s Biologics License Application for TAB014 for wAMD Accepted for Review by the NMPA

Zhaoke Ophthalmology Obtains FDA Clearance for CsA Ophthalmic Gel’s IND Application in the U.S.